News Ticker

Biotech Networks Trending News

  • San Francisco
  • Boston/Cambridge
  • San Diego
  • Pennsylvania NY NJ
  • DC Maryland Virginia
  • Washington/Oregon
  • Los Angeles
Dablicator Retail Revenues Surpass $100MM as it Enters Brand Partnership with TerrAscend
Valent U.S.A. launches new science-based framework to help growers advance sustainable agricultural production
Triumvira Immunologics Highlights Positive Phase 1 Clinical Data on TAC01-HER2 in Solid Tumors at ASCO 2023 Annual Meeting
IDEAYA Biosciences to Participate in Upcoming June 2023 Investor Relations Events
Pionyr Immunotherapeutics’ Phase 1a Study of TREM1-targeting Antibody PY159 for the Treatment of Solid Tumors Featured at ASCO 2023
Revenue Cycle Associates Connects with Prodigal to Drive RCM Outcomes
Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-SPY2 TRIAL at ASCO
Biotech Networks Event: Speed Networking in San Francisco April 24th 2023
Scoop: Just months after Sanofi AI deal, Atomwise laid off 30% of staffers amid 'strategic shift'
Nektar Announces Promotion of Jillian B. Thomsen to Senior Vice President & Chief Financial Officer
Compass Medical suddenly closes all facilities
Pinetree Therapeutics Announces Two Appointments to Strengthen its Scientific Leadership
Boston Scientific Announces Conversion Date of Series A Mandatory Convertible Preferred Stock
ABCAM PLC: Statement on calling an Extraordinary General Meeting
#WhyIScience Q&A: A process development lead returns to her research roots
Mass. insurance regulators investigate Point32Health data breach
Quibim, a company leveraging artificial intelligence to improve cancer diagnostics, makes key move into U.S. by hiring Boston-based chief medical officer
Foundation Medicine and Its Collaborators Announce Acceptance of 21 Abstracts at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Biotech Networks Event: Speed Networking Boston & BIO June 6th 2023
MIT graduate engineering, business, science programs ranked highly by U.S. News for 2023-24
Shareholder vote totals in Illumina's proxy fight with activist Carl Icahn show support, frustration
Mirati Therapeutics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference 2023
Illumina unveils AI software to predict disease-causing genetic mutations in patients
Debut Raises $34M in Series B Funding Led by L'Oréal To Create the Next Generation of High-Performing Active Ingredients
CureScience™ Institute Publishes A Review Article on Neoantigens
Navigate BioPharma Services, Inc. launches new multiplex digital PCR assay for comprehensive quantification of up to 5 different CAR-T transgenes
Bayer buys license to Cedilla preclinical cancer program; MEI Pharma says no to unsolicited offer
Rethink, Rewrite, Redefine—How Biodegradable Plastics Are Reshaping Sustainability
New UC San Diego Entrepreneurship Lab Launches Program to Get Startups off the Ground
Poseida Therapeutics Announces Virtual 2023 Annual Meeting of Stockholders
Jefferson executive takes new job as senior advisor to local venture capitalist
Seagen Stockholders Approve Acquisition by Pfizer
ASCO: Regeneron's Opdualag rival records double the historical response rate in melanoma
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health Announce Three Late-Breaking Presentations at the 2023 ASCO Annual Meeting
Merck Highlights Commitment to Improving Cancer Outcomes at ASCO 2023
Pfizer Presents Scientific Advancements from its Leading Oncology Portfolio at ASCO 2023 Annual Meeting
ASCO puts spotlight on advancing antibody-drug conjugate pipeline
AION Labs, In Continued Partnership with BioMed X, Launches New Global Call for Applications: Identification of Active Small Molecules for Drug Discovery
District court hands Janssen a win in patent feud with Viatris
CenTrak Expands RTLS Wi-Fi Offerings and Multi-Mode Capabilities
Sirnaomics Dosed the First Patient in Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment
FDA Conducts Retailer Inspection Blitz, Cracks Down on Illegal Sales of Popular Disposable E-cigarettes
BAE Systems launches technology partner program for core national security missions
FDA Proposes New, Easy-to-Read Medication Guide for Patients, Patient Medication Information
FDA Roundup: May 26, 2023
Gaithersburg diagnostic company Hememics Biotechnologies nabs millions ahead of larger funding round
Opinion: How ‘Lessons From the Covid War’ falls short
Francis Collins readies a Biden push to eliminate hepatitis C nationwide
Amazon to shut down its Amazon Care telehealth service at end of year
Aligned Orthopedic Partners Announces Strategic Partnership with Jordan-Young Institute
Seagen shareholders approve $43B acquisition by Pfizer
Opinion: What you need to know about Washington's long-term care payroll tax
InnerTrek plans to open psilocybin service center in Portland
National Kidney Foundation Appoints Former U.S. Congresswoman Jaime Herrera Beutler to National Board of Directors
Seal Rock Therapeutics Announces Out-Licensing Agreement with GENFIT for Development of Injectable Formulation of SRT-015 for Acute-on-Chronic Liver Disease (ACLF)
Nurse staffing bill is likely among the casualties of Oregon Senate Republican walkout
Life Time Opens First Luxury Athletic Country Club and Life Time Work in Oregon on May 31
NanoString to Webcast Presentation from Jefferies Healthcare Conference
What Is The Best Cream To Remove Scars?
Milliman Medical Index: Healthcare costs exceed $31,000 for hypothetical American family of four
Amgen's new YouTube series gives voice to cancer patients' points of view
TORL BioTherapeutics Announces Initial Results of Novel Claudin 6 (CLDN6) Targeted Antibody Drug Conjugate (ADC) TORL-1-23 Selected for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Agendia Studies Reveal the Influence of Race on a Tumor’s Biology, Reinforcing its Commitment to Advancing Research of Racial Disparities in Breast Cancer
Dropstat Extends its AI-Powered Solution to Revolutionize Healthcare Staffing
AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023
Xencor Presents Clinical Results from Phase 1a Study of XmAb®564 at the EULAR 2023 Congress
Govise Co-Founder Selected for WomLEAD Magazine Cover Story
AMGEN TO PRESENT AT THE TD COWEN 4TH ANNUAL ONCOLOGY INNOVATION SUMMIT
Fitness & Yoga Campus, Camp Los Angeles, Warms Up for Summer Expansion in West L.A.
FTC expands PBM investigation to include rebate negotiators

Follow/Subscribe

© 2022 Biotech Networks, LLC